Camurus AB (publ)
SSE:CAMX.ST
Overview | Financials
Company Name | Camurus AB (publ) |
Symbol | CAMX.ST |
Currency | SEK |
Price | 440 |
Market Cap | 25,354,384,000 |
Dividend Yield | 0% |
52-week-range | 197.6 - 599.5 |
Industry | Biotechnology |
Sector | Healthcare |
CEO | Mr. Fredrik Tiberg |
Website | https://www.camurus.com |
An error occurred while fetching data.
About Camurus AB (publ)
Camurus AB (publ), a pharmaceutical company, develops and commercializes medicines for severe and chronic conditions in Europe, Australia, the United States, Japan, and internationally. The company offers Buvidal, a buprenorphine injection for the treatment of opioid dependence; episil oral liquid, a medical device for the treatment of inflammatory and painful
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD